Unfortunately, diabetes is affecting more patients than ever, and that's made DexCom a key provider in helping people fight the disease without having to do repeated glucose checks on their own all the time.However, with a history that includes the successful Ebola virus treatment it developed, Regeneron has medical professionals feeling optimistic about the company's prospects for coming out with a sequel.